Company intelligence / Profile preview

Spraino

Copenhagen, Denmarkspraino.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Clinical studies show that the Spraino low-friction shoe patch reduces severe ankle sprain injuries by over 50% in randomized controlled trials[3]. The device has also been shown to reduce harmful forces during a twist by more than 90%, prevent almost 60% of serious ankle injuries, and reduce injury time by up to 67%[2].

"In a recent 510-athlete randomized controlled trial, allocation to this 'low-friction' shoe-patch resulted in a 53% reduction of severe ankle sprain injuries."[3]

"Reduces harmful forces during a twist by more than 90%. Prevents almost 60% of serious ankle injuries. Reduces injury time by up to 67%"[2]

Products are available for both sports performance/injury prevention and for medical gait aid.

No evidence of drug development or traditional clinical trial phases.

Therapeutic areas
OtherNeurology
Modalities
DeviceNon-pharmacological therapy (low-friction shoe patch)
Industry
Assistive Medical Devices
02

Partnerships

Institute of Biomechanics at German Sports College CologneDept. of Orthopedics at Hvidovre University HospitalDepartment of Mechanics at Danish Technical UniversityDepartment of Orthopedics at Odense University HospitalAalborg University

Beyond the preview

Go deeper on Spraino.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spraino.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call